Aspira Women’s Health (AWH) Cash Flow Statement

Click line-items for a historical chart and %

Net income	296.1M
Net realized gains on sales of investments	-37.7M
Mark to market adjustments	-91.1M
Net impairment charges recognized in earnings
Stock based compensation	13.4M
Insurance balances receivable	-148.8M
Prepaid reinsurance
Reinsurance recoverable	-32.6M
Accrued investment income
Net deferred acquisition costs	7.5M
Net deferred tax assets
Other assets
Reserve for losses and loss expenses
Unearned premiums
Reinsurance balances payable	44.1M
Accounts payable and accrued liabilities	-28.2M
Other items, net
Net cash provided by operating activities
Purchases of fixed maturity investments - available for sale
Purchases of fixed maturity investments
Purchases of fixed maturity investments - trading
Purchases of equity securities
Purchases of other invested assets	-58.5M
Sales of fixed maturity investments - available for sale
Sales of fixed maturity investments - trading	4.6B
Sales of equity securities
Sales of other invested assets	99.2M
Purchases of fixed assets	-3.1M
Change in restricted cash	-38.2M
Net cash used in investing activities
Dividends paid	-68.8M
Proceeds from the exercise of stock options	7.7M
Share repurchases	-165.7M
Repurchase of founder warrants
Net cash used in financing activities
Effect of exchange rate changes on foreign currency cash	1.9M
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	165.8M
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	608M
CASH AND CASH EQUIVALENTS, END OF PERIOD	773.8M
Cash paid for income taxes	2.3M
Cash paid for interest expense	56.6M

Entities mentioned with AWH

View All Entities